ICAM1 and systemic sclerosis: A hallmark of SSc vascular activation is up-regulation of ICAM-1 in endothelial cells40,59, and ICAM-1 deficiency significantly attenuates bleomycin-induced dermal fibrosis by decreasing inflammatory Th2/Th17 cell accumulation39.